The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 11, 2022

Filed:

May. 11, 2018
Applicant:

Marshall University Research Corporation, Huntington, WV (US);

Inventors:

Zijian Xie, Saline, MI (US);

Jiayan Wang, Huntington, WV (US);

Sandrine V. Pierre, Huntington, WV (US);

Joseph I. Shapiro, Huntington, WV (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/10 (2006.01); A61K 38/00 (2006.01); A61K 38/46 (2006.01); C07K 14/00 (2006.01); C07K 7/08 (2006.01); A61P 9/12 (2006.01); A61P 9/10 (2006.01);
U.S. Cl.
CPC ...
C07K 7/08 (2013.01); A61P 9/12 (2018.01); C07K 14/00 (2013.01); A61K 38/00 (2013.01);
Abstract

Methods treating pulmonary hypertension, including pulmonary arterial hypertension, are provided, and include administering a polypeptide antagonist of a Na/K ATPase/Src receptor complex to a subject in need thereof. Administration of the polypeptide antagonist reduces pulmonary artery acceleration time, reduces an amount of right ventricular hypertrophy, reduces right ventricular wall thickness, reduces an amount of pulmonary vessel wall thickness, reduces an amount of plexiform lesions in a lung of the subject, reduces an amount of collagen deposition in a pulmonary blood vessel, reduces an amount of collagen deposition in a pulmonary blood vessel media or adventitia, and/or reduces an amount of right ventricular fibrosis. Methods of reducing pulmonary vessel wall thickness are also provided and include the administration of the polypeptide antagonist of a Na/K ATPase/Src receptor complex.


Find Patent Forward Citations

Loading…